SMTSTRATEGIES GLOBAL
All resources

Healthcare interoperability · 2026-11-02

Oman Is About to Catch FHIR

Oman’s interoperability opportunity: what Dhamani, SIJL, and national health-record plans mean for HL7 FHIR vendors entering the market.

Conceptual illustration of healthcare buildings in Muscat connected by green and orange data pathways

What healthcare interoperability brands need to understand about Oman’s next phase

Oman is about to catch FHIR. Before anyone reaches for an extinguisher, I mean Fast Healthcare Interoperability Resources, the health-data exchange standard published by HL7. The wordplay is new; Oman’s investment in digital health is not. HL7’s FHIR overview explains the standard, but understanding the specification is only the beginning of understanding a market.

For healthcare technology companies considering Oman, I see a more interesting question than whether FHIR has arrived: what will it take to turn standards-based connectivity into dependable clinical and business operations? The Ministry of Health’s November 1, 2026 announcement of SIJL, a national platform for accrediting health information systems and data exchange, makes that question especially timely. My advice is to study the responsibilities around the connection as carefully as the connection itself.

1. Oman’s healthcare interoperability story did not begin with FHIR

I would not enter this market with a presentation suggesting Oman is waiting for someone to introduce electronic health records. The Ministry describes an established ecosystem: Al-Shifa supports health records within facilities; Nahr Al-Shifa is the national electronic health-record initiative; and Nabdh Al-Shifa supports centralized information and analytics. These names refer to different functions, not interchangeable labels for one product. Source: MOH digital-health directorate.

That history changes the commercial conversation. An incoming vendor needs to understand existing systems, interfaces, workflows, and ownership before proposing replacement architecture. Ask what the organization already exchanges, which counterparties receive it, and which staff resolve exceptions. A convincing demonstration should fit that environment rather than assume an empty implementation landscape.

I distinguish three tasks when reviewing an interoperability opportunity: exchanging information, preserving its meaning, and enabling the receiving team to act. A technically successful transfer can still leave someone reconciling identifiers or chasing clarification. Treat those operational questions as discovery work. They are not evidence that every Omani organization has the same problem.

2. Dhamani makes the exchange conversation practical

Dhamani is a useful example because it connects interoperability with insurance workflows. The Financial Services Authority describes it as an exchange platform and identifies HL7 FHIR among its standards. Its public guidance covers eligibility, preauthorization, claims, and related processes. Source: FSA Dhamani FAQ.

For vendors, that provides a concrete starting point. Which part of the provider-payer journey does your product support? Does it help prepare information, exchange it, interpret a response, route an exception, or reconcile the result? Be specific about the boundary between your software and someone else’s responsibility.

The FSA also distinguishes the platform’s exchange role from insurers’ approval decisions. That matters commercially: a vendor should not market technical acceptance as a guarantee of authorization or payment. In a demonstration, show the different statuses and explain the next action for each. Do not let a green checkmark do more work than the contract permits.

Dhamani integration and national clinical-record exchange should also remain distinct in a market-entry plan. Experience with one pathway may be relevant to another, but it does not establish approval, eligibility, or technical conformity across every programme. Verify the applicable pathway with its responsible authority and customer.

3. SIJL gives health IT vendors a new diligence priority

On November 1, 2026, the Ministry of Health announced SIJL, describing a platform for registering health-system providers and assessing systems against technical and regulatory requirements before accreditation. The first phase focuses on provider registration, documents, and assessments. That is an announced process, not proof that every system has already completed it. Source: MOH SIJL launch announcement.

The published service page describes evidence-based self-assessment, National Health Record sandbox testing, Ministry review, and accreditation for each system version. It lists Omani Commercial Registration requirements for relevant private applicants and a condition that health data and backups are stored within Oman. These are requirements stated for that service, not a substitute for reviewing every applicable legal obligation. Source: MOH SIJL service.

My commercial interpretation is straightforward: assess eligibility, deployment architecture, documentation, and testing responsibilities before promising a delivery date. An overseas company should ask the Ministry how its proposed commercial structure fits the published applicant categories. A reseller relationship alone should not be treated as an answer.

I would build a requirement register with an official source, applicability decision, accountable owner, required evidence, and review date. Ask how upgrades affect the accredited system version and what further review is needed. That small discipline can prevent a sales promise from becoming an implementation surprise.

4. HL7 and FHIR are related, but the terms are not interchangeable

HL7 publishes multiple standards. FHIR represents healthcare information through reusable resources, such as Patient and Observation. HL7 Version 2 uses messages and segments to communicate events and information. The approaches can coexist; adopting FHIR does not automatically retire existing interfaces. Sources: HL7 FHIR overview and HL7’s comparison with Version 2.

A FHIR profile adapts the base standard to a particular context. An implementation guide brings related adaptations together. Consequently, saying “we support FHIR” leaves important questions unanswered: which release, which profiles, which terminology, and which interactions? Source: HL7 profiling guidance.

For an Oman healthcare interoperability project, obtain the applicable specifications and acceptance criteria from the responsible programme or authorized counterparty. Do not substitute a U.S. implementation guide, a neighboring country’s requirements, or your product’s default configuration. Those may inform the engineering discussion, but they do not establish the local requirements.

FHIR is also not a security protocol. HL7 explicitly places security responsibilities around its exchange models. Identity, authorization, secure communications, and audit arrangements still require implementation decisions. Source: HL7 FHIR security guidance. A standards logo belongs in a capabilities discussion, not in place of a security review.

5. What comes next: distinguish the published direction from the forecast

The Ministry’s Shifa application page describes expansion of public-private electronic integration as a phased, long-term plan toward interoperability within the unified health record. That supports a direction of travel. It does not establish universal connectivity today or a single completion date. Source: MOH Shifa application.

Taken together, these official publications suggest that vendors should prepare for closer scrutiny of system evidence and cross-organizational exchange. That is my interpretation of the published direction, not a procurement announcement or a forecast of contract volume. A national objective does not tell us which organization has a budget this quarter.

I would expect buyers to ask increasingly practical questions: can the system meet the applicable requirements, can the team demonstrate it, and who supports it after deployment? Validate that hypothesis through buyer interviews. Ask about funded priorities, decision authority, existing suppliers, and procurement timing before calling an opportunity qualified.

6. Where interoperability brands can investigate commercial opportunities

I see four areas worth testing with prospective customers. These are discovery hypotheses, not claims of unmet demand at named institutions.

Integration and migration support. Investigate the effort required to connect existing applications, preserve necessary information, and manage interface changes. Ask the customer to identify a specific exchange and its acceptance criteria before scoping an integration engine or FHIR service.

Data quality and terminology. Explore whether identifiers, code mappings, mandatory fields, or source-record inconsistencies create rework. Agree on a measurable baseline and who can correct the underlying data. A mapping tool cannot compensate indefinitely for an unresolved source process.

Testing and operational assurance. Ask whether customers need support preparing evidence, exercising failure scenarios, reviewing acknowledgments, and confirming recovery. Keep independent testing support distinct from formal accreditation. Only the relevant authority can determine the official outcome.

Workforce and workflow education. Investigate whether IT, clinical, insurance, and operations teams share the same understanding of statuses and escalation routes. Offer training around an agreed task, then assess whether participants can perform it. Attendance is a delivery measure; demonstrated competence is a different measure.

For each opportunity, identify the user, budget owner, purchasing route, and organization responsible for accepting the work. Those answers are more commercially useful than a broad statement about the size of Oman’s digital-health ambitions.

7. Build an Oman market-entry plan buyers can evaluate

I would organize the first discovery and delivery proposal around six decisions:

  1. Choose one use case. Define the sending system, receiving party, information exchanged, and operational decision supported. Start with a bounded workflow rather than a promise to connect everything.
  2. Confirm the applicable pathway. Separate Dhamani, national-record integration, SIJL, and customer-specific requirements. Record authoritative sources and unresolved questions. Do not assume one approval covers the others.
  3. Establish local delivery responsibilities. Identify who owns commercial eligibility, hosting, testing, training, and ongoing support. Agree what a local partner actually does and how the customer escalates an issue.
  4. Agree on evidence of success. Define measures such as reconciliation time, missing-data frequency, or exception closure. Identify the denominator, measurement period, and exclusions so a positive result means the same thing to both parties.
  5. Test failure as well as success. Use authorized test data to exercise duplicate information, incomplete records, rejected transactions, access failures, and recovery. Choose scenarios appropriate to the agreed use case.
  6. Plan the transition into operations. Name the support owner, handover criteria, documentation, change process, and review schedule. Price those responsibilities rather than leaving them hidden beneath “implementation included.”

A pilot should answer a purchasing question. If the parties cannot explain what decision follows the results, refine the scope before starting. Activity can fill a calendar quite comfortably without establishing a business case.

8. The marketing message should survive the technical meeting

For healthcare interoperability brands, I would replace broad promises with a verifiable proposition: the workflow supported, the requirements addressed, the evidence available, and the responsibilities retained by the customer. Claims about interoperability should be narrow enough for an engineer to test and clear enough for an operations leader to understand.

Build educational content around the questions buyers are already asking: Dhamani integration in Oman, HL7 FHIR readiness, SIJL system accreditation, national health-record integration, and health-data governance. Use these terms naturally. A keyword earns its place when the page answers the corresponding question.

Show an illustrative workflow, a test approach, and a responsibility matrix. Explain limitations alongside capability. Publish customer results only with permission and enough context to make them meaningful. A product demonstration should create informed confidence, not leave the customer to discover the exclusions during implementation.

Turn the interoperability opportunity into a credible next step

Oman’s interoperability story combines established digital-health infrastructure, insurance exchange, and an evolving framework for assessing health information systems. I see an opportunity for brands that can understand the local pathway and demonstrate useful performance within it. Winning attention is one task. Delivering a supported workflow is the task that keeps the relationship.

If your company is evaluating Oman, bring one use case, your delivery assumptions, and the evidence behind your capabilities to SMT Strategies Global. For provider teams reviewing claims operations, explore our Dhamani Claims Readiness Toolkit. Start with a question your team needs to answer, then build the connection, responsibilities, and proof around it.

*By Shereese Maynard, MS, MBA. Published November 2, 2026. Official sources reviewed on that date. This article offers independent market-entry analysis; it is not an official implementation specification, legal opinion, or accreditation decision.*